NCT00876343View on ClinicalTrials.gov

Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

586

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Major Depressive Disorder
Interventions
DRUG

Aripiprazole (Fixed dose)

administered orally once daily, 3 mg daily, 6 weeks

DRUG

Aripiprazole (Titrated dose)

administered orally once daily, 3 to 15 mg daily, 6 weeks

DRUG

Placebo

administered orally once daily, 6 weeks

Trial Locations (8)

Unknown

Chubu Region

Chugoku Region

Hokkaido Region

Kanto Region

Kinki Region

Kyushu Region

Shikoku Region

Tohoku Region

Sponsors
All Listed Sponsors
lead

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY